Paper

Palmitoylethanolamide in CNS health and disease.

Published Aug 1, 2014 · G. Mattace Raso, R. Russo, A. Calignano

Pharmacological research

131

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

Palmitoylethanolamide (PEA) has antihyperalgesic and neuroprotective properties in the central nervous system, potentially benefiting patients with neurodegenerative diseases.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Palmitoylethanolamide in CNS health and disease.

References

Citations